Omnicell Valuation

OC9 Stock  EUR 32.60  1.40  4.49%   
At this time, the company appears to be overvalued. Omnicell holds a recent Real Value of €29.12 per share. The prevailing price of the company is €32.6. Our model determines the value of Omnicell from analyzing the company fundamentals such as Operating Margin of 0.01 %, shares outstanding of 44.88 M, and Return On Equity of 0.0017 as well as examining its technical indicators and probability of bankruptcy.
Price Book
1.3057
Enterprise Value
1.4 B
Enterprise Value Ebitda
17.7992
Price Sales
1.2722
Forward PE
28.0112
Overvalued
Today
32.60
Please note that Omnicell's price fluctuation is not too volatile at this time. Calculation of the real value of Omnicell is based on 3 months time horizon. Increasing Omnicell's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Omnicell stock is determined by what a typical buyer is willing to pay for full or partial control of Omnicell. Since Omnicell is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Omnicell Stock. However, Omnicell's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  32.6 Real  29.12 Hype  32.66 Naive  32.18
The real value of Omnicell Stock, also known as its intrinsic value, is the underlying worth of Omnicell Company, which is reflected in its stock price. It is based on Omnicell's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Omnicell's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
29.12
Real Value
32.95
Upside
Estimating the potential upside or downside of Omnicell helps investors to forecast how Omnicell stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Omnicell more accurately as focusing exclusively on Omnicell's fundamentals will not take into account other important factors:
Earnings
Estimates
LowProjectedHigh
0.880.910.94
Details
Hype
Prediction
LowEstimatedHigh
28.8332.6636.49
Details
Naive
Forecast
LowNext ValueHigh
28.3532.1836.01
Details

Omnicell Cash

249.19 Million

Omnicell Total Value Analysis

Omnicell is now estimated to have takeover price of 1.38 B with market capitalization of 1.51 B, debt of 174.32 M, and cash on hands of 77.24 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Omnicell fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
1.38 B
1.51 B
174.32 M
77.24 M

Omnicell Investor Information

About 98.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.31. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Omnicell had not issued any dividends in recent years. Omnicell is not in a good financial situation at this time. It has a very high odds of going through financial crisis in March.
Current ValueLast YearChange From Last Year 10 Year Trend
Total Cash From Operating Activities133.5 M215.9 M
Way Down
Slightly volatile

Omnicell Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Omnicell implies not a very effective usage of assets in February.
 
Covid
 
Interest Hikes

Omnicell Profitability Analysis

Taking into consideration Omnicell's profitability measurements, Omnicell may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess Omnicell's ability to earn profits and add value for shareholders.
 
Net Income  
First Reported
2016-12-31
Previous Quarter
5.6 M
Current Value
5.5 M
Quarterly Volatility
12.5 M
 
Covid
 
Interest Hikes
The current Gross Profit is estimated to decrease to about 445.2 M
For Omnicell profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Omnicell to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Omnicell utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Omnicell's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Omnicell over time as well as its relative position and ranking within its peers.

Omnicell Earnings per Share Projection vs Actual

By analyzing Omnicell's earnings estimates, investors can diagnose different trends across Omnicell's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Omnicell is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
 
Interest Hikes
Omnicell is projected to generate 0.91 in earnings per share on the 30th of September 2021. Omnicell earnings estimates show analyst consensus about projected Omnicell EPS (Earning Per Share). It derives the highest and the lowest estimates based on Omnicell's historical volatility. Many public companies, such as Omnicell, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Omnicell Ownership Allocation

Omnicell has a total of 44.88 Million outstanding shares. The majority of Omnicell outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Omnicell to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Omnicell. Please pay attention to any change in the institutional holdings of Omnicell as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.

Omnicell Profitability Analysis

The company reported the revenue of 1.11 B. Net Income was 12.53 M with profit before overhead, payroll, taxes, and interest of 508.04 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Omnicell's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Omnicell and how it compares across the competition.

About Omnicell Valuation

The stock valuation mechanism determines Omnicell's current worth on a weekly basis. Our valuation model uses a comparative analysis of Omnicell. We calculate exposure to Omnicell's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Omnicell's related companies.
Last ReportedProjected for Next Year
Gross Profit541.7 M445.2 M

Omnicell Quarterly Retained Earnings

386.97 Million

Complementary Tools for Omnicell Stock analysis

When running Omnicell's price analysis, check to measure Omnicell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omnicell is operating at the current time. Most of Omnicell's value examination focuses on studying past and present price action to predict the probability of Omnicell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omnicell's price. Additionally, you may evaluate how the addition of Omnicell to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals